» Authors » Rhona J Souers

Rhona J Souers

Explore the profile of Rhona J Souers including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 103
Citations 328
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Vos J, Venkataraman G, Jiang L, Blond B, Coulter S, Souers R
Arch Pathol Lab Med . 2024 Dec; PMID: 39716877
Context.—: Morphologic evaluation of peripheral blood smears provides valuable information to diagnose and manage a variety of hematologic disorders. Objective.—: To measure the competency of the technical staff in the...
2.
Furtado L, Kim A, Moyer A, Moncur J, Xian R, Roy A, et al.
Arch Pathol Lab Med . 2024 Nov; PMID: 39576195
Context.—: Genomic reports are primarily organized in a narrative and unstructured format with variations in content and format. Regulatory requirements and professional guidelines for genetic test reporting exist but provide...
3.
Sullivan K, Souers R, Hillesland E, Pillai D, Rhoads D, Rolf R, et al.
Arch Pathol Lab Med . 2024 Aug; PMID: 39101237
Context.—: Laboratory testing practices for diagnosis of Clostridioides difficile infection (CDI) have evolved in response to published guidelines, availability of highly sensitive nucleic acid amplification tests (NAATs), perceived problems with...
4.
Austin A, Broaddus R, Souers R, Kane M, Kolhe R, Miller D, et al.
Am J Clin Pathol . 2024 Jul; 163(1):60-68. PMID: 39078096
Objectives: To describe mismatch repair (MMR) and microsatellite instability (MSI) testing practices in laboratories using the College of American Pathologists (CAP) MSI/MMR proficiency testing programs prior to the 2022 publication...
5.
6.
Chambliss A, Souers R, Genzen J, Manthei D
Arch Pathol Lab Med . 2024 Jul; PMID: 39048110
Context.—: Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) assay reagents are available both with and without supplementation with pyridoxal-5'-phosphate (P5P; the active form of vitamin B6), a catalytic cofactor required...
7.
Nguyen L, Crothers B, Souers R, Barkan G, Brainard J, Nassar A, et al.
Arch Pathol Lab Med . 2023 Dec; 148(8):871-879. PMID: 38051268
Context.—: Cytologic-histologic correlation (CHC) is a Clinical Laboratory Improvement Amendments-mandated requirement for gynecologic cytology, but no similar requirement exists for nongynecologic cytology. This study presents the findings from a College...
8.
Hanna M, Olson N, Zarella M, Dash R, Herrmann M, Furtado L, et al.
Arch Pathol Lab Med . 2023 Dec; 148(10):e335-e361. PMID: 38041522
Context.—: Machine learning applications in the pathology clinical domain are emerging rapidly. As decision support systems continue to mature, laboratories will increasingly need guidance to evaluate their performance in clinical...
9.
Tsuchiya K, Funke B, Hegde M, Santani A, Souers R, Szelinger S, et al.
Arch Pathol Lab Med . 2023 Oct; 148(7):775-783. PMID: 37852169
Context.—: Next-generation sequencing (NGS)-based assays are used for diagnosis of diverse inherited disorders. Limited data are available pertaining to interlaboratory analytical performance of these assays. Objective.—: To report on the...
10.
Zehir A, Nardi V, Konnick E, Lockwood C, Long T, Sidiropoulos N, et al.
Arch Pathol Lab Med . 2023 Sep; 148(2):139-148. PMID: 37776255
Context.—: The Sustainable Predictive Oncology Therapeutics and Diagnostics quality assurance pilot study (SPOT/Dx pilot) on molecular oncology next-generation sequencing (NGS) reportedly demonstrated performance limitations of NGS laboratory-developed tests, including discrepancies...